Annual Cash & Cash Equivalents
$21.67 M
-$22.68 M-51.14%
31 December 2022
Summary:
Catalyst Biosciences annual cash & cash equivalents is currently $21.67 million, with the most recent change of -$22.68 million (-51.14%) on 31 December 2022. During the last 3 years, it has fallen by -$8.69 million (-28.64%).CBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.23 M
-$4.70 M-67.82%
30 September 2023
Summary:
Catalyst Biosciences quarterly cash and cash equivalents is currently $2.23 million, with the most recent change of -$4.70 million (-67.82%) on 30 September 2023.CBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -28.6% | -96.2% |
| 5 y5 years | -30.6% | -90.3% |
CBIO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -86.9% | -99.1% |
Catalyst Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $2.23 M(-67.8%) |
| June 2023 | - | $6.92 M(-14.5%) |
| Mar 2023 | - | $8.10 M(-62.6%) |
| Dec 2022 | $21.67 M(-51.1%) | $21.67 M(-6.2%) |
| Sept 2022 | - | $23.09 M(-69.4%) |
| June 2022 | - | $75.39 M(+116.5%) |
| Mar 2022 | - | $34.82 M(-21.5%) |
| Dec 2021 | $44.35 M(+46.1%) | $44.35 M(-25.0%) |
| Sept 2021 | - | $59.16 M(-19.6%) |
| June 2021 | - | $73.62 M(-11.3%) |
| Mar 2021 | - | $83.04 M(+173.5%) |
| Dec 2020 | $30.36 M(+97.5%) | $30.36 M(+21.8%) |
| Sept 2020 | - | $24.92 M(-58.0%) |
| June 2020 | - | $59.27 M(-15.8%) |
| Mar 2020 | - | $70.36 M(+357.8%) |
| Dec 2019 | $15.37 M(-50.8%) | $15.37 M(-33.2%) |
| Sept 2019 | - | $23.02 M(+32.7%) |
| June 2019 | - | $17.35 M(-30.7%) |
| Mar 2019 | - | $25.02 M(-19.8%) |
| Dec 2018 | $31.21 M(+115.7%) | $31.21 M(-13.3%) |
| Sept 2018 | - | $36.00 M(-22.6%) |
| June 2018 | - | $46.53 M(-63.2%) |
| Mar 2018 | - | $126.55 M(+774.4%) |
| Dec 2017 | $14.47 M(+41.0%) | $14.47 M(+31.9%) |
| Sept 2017 | - | $10.97 M(-66.1%) |
| June 2017 | - | $32.39 M(+122.9%) |
| Mar 2017 | - | $14.53 M(+41.6%) |
| Dec 2016 | $10.26 M(-64.7%) | $10.26 M(+10.2%) |
| Sept 2016 | - | $9.32 M(-17.8%) |
| June 2016 | - | $11.33 M(-44.9%) |
| Mar 2016 | - | $20.58 M(-29.3%) |
| Dec 2015 | $29.10 M(-48.4%) | $29.10 M(+26.0%) |
| Sept 2015 | - | $23.10 M(-70.5%) |
| June 2015 | - | $78.20 M(+7.0%) |
| Mar 2015 | - | $73.11 M(+29.6%) |
| Dec 2014 | $56.43 M | $56.43 M(+23.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $45.71 M(+5.3%) |
| June 2014 | - | $43.42 M(-3.6%) |
| Mar 2014 | - | $45.04 M(-17.3%) |
| Dec 2013 | $54.48 M(-33.7%) | $54.48 M(-11.7%) |
| Sept 2013 | - | $61.74 M(-2.1%) |
| June 2013 | - | $63.06 M(-9.7%) |
| Mar 2013 | - | $69.86 M(-15.1%) |
| Dec 2012 | $82.24 M(-23.3%) | $82.24 M(+5.2%) |
| Sept 2012 | - | $78.20 M(+9.2%) |
| June 2012 | - | $71.64 M(-19.2%) |
| Mar 2012 | - | $88.67 M(-17.4%) |
| Dec 2011 | $107.28 M(-35.3%) | $107.28 M(-17.8%) |
| Sept 2011 | - | $130.54 M(-22.4%) |
| June 2011 | - | $168.14 M(+21.1%) |
| Mar 2011 | - | $138.84 M(-16.3%) |
| Dec 2010 | $165.85 M(+97.7%) | $165.85 M(-10.7%) |
| Sept 2010 | - | $185.80 M(-16.2%) |
| June 2010 | - | $221.63 M(-8.4%) |
| Mar 2010 | - | $241.95 M(+188.3%) |
| Dec 2009 | $83.91 M(+63.9%) | $83.91 M(+74.0%) |
| Sept 2009 | - | $48.23 M(+5.0%) |
| June 2009 | - | $45.92 M(+6.8%) |
| Mar 2009 | - | $43.01 M(-16.0%) |
| Dec 2008 | $51.20 M(-4.1%) | $51.20 M(-16.7%) |
| Sept 2008 | - | $61.50 M(-4.4%) |
| June 2008 | - | $64.37 M(-1.7%) |
| Mar 2008 | - | $65.47 M(+22.6%) |
| Dec 2007 | $53.40 M(+27.9%) | $53.40 M(+3.0%) |
| Sept 2007 | - | $51.87 M(+21.8%) |
| June 2007 | - | $42.59 M(-22.8%) |
| Mar 2007 | - | $55.18 M(+32.2%) |
| Dec 2006 | $41.74 M(+68.0%) | $41.74 M(-10.3%) |
| Sept 2006 | - | $46.51 M(-9.5%) |
| June 2006 | - | $51.38 M(+88.9%) |
| Mar 2006 | - | $27.20 M(+9.5%) |
| Dec 2005 | $24.85 M(-53.2%) | $24.85 M |
| Dec 2004 | $53.08 M | - |
FAQ
- What is Catalyst Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Catalyst Biosciences?
What is Catalyst Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CBIO is $21.67 M
What is the all time high annual cash & cash equivalents for Catalyst Biosciences?
Catalyst Biosciences all-time high annual cash & cash equivalents is $165.85 M
What is Catalyst Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CBIO is $2.23 M
What is the all time high quarterly cash and cash equivalents for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly cash and cash equivalents is $241.95 M